Trial Profile
Randomised Trial of Contrast-enhanced Sonothrombolysis in acute ischaemic stroke
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 16 Apr 2020
Price :
$35
*
At a glance
- Drugs Alteplase (Primary) ; Sulfur hexafluoride (Primary) ; Tenecteplase
- Indications Stroke
- Focus Adverse reactions; Proof of concept; Therapeutic Use
- Acronyms NOR-SASS; NOR-SASS 2
- 30 Sep 2019 Planned End Date changed from 1 Dec 2019 to 31 Dec 2022.
- 30 Sep 2019 Planned primary completion date changed from 1 Dec 2019 to 31 Dec 2022.
- 01 Mar 2017 Planned number of patients changed from 300 to 180.